This fragrance company is trying to recreate the scent of extinct blooms
Working together with the Harvard University Herbaria — home to over five million botanical specimens — Future Society has successfully sequenced the genetic codes of preserved plants, some of which date back more than 150 years. Six of them have already been made into perfumes, with signature notes ranging from the green to woody and floral.
Take the orbexilum stipulatum, a herbaceous, flowering plant that grew on Rock Island in the shallowest part of the old Falls of the Ohio and is last known to have flowered in 1881. The plant is thought to have been wiped out after the eradication of buffalo that used to migrate through the area, meaning its seeds were no longer dispersed far and wide. Then in the 1920s, the entire area was flooded by dams, submerging all hope for it.
'We set out to make scents we've never smelled before and fragrances that were previously not possible to make,' said Jasmina Aganovic, founder and CEO of Future Society and its parent company Arcaea, in a video interview with CNN.
The six fragrances, Aganovic explained, have been made possible by DNA sequencing. 'It's similar (to the) technology that was used on ancestry.com and 23andme whereby users spit into a tube, send it away and wait to find out about their genetics,' she said. 'We used this technology on preserved plant specimens from extinct flowers, searching for scent molecules which started to provide a glimpse into what these extinct flowers might have smelled like.'
Not an exact science
Aganovic didn't set out with a grand plan for a certain flower she was desperate to smell, but wanted to demonstrate how new biological advancements could be used in the beauty sector.
In a 'not very romantic' fashion, the Future Society team looked at how many specimens existed in the Harvard University Herbaria, how many samples they could get and which of those would be reconstructible, because DNA degrades over time, she said. 'Ultimately we didn't know if this de-extincting exercise was going to work, so it was a numbers game to try it out.'
On the process, Aganovic explained: 'The actual specimens are small little snippets brought back to the lab and they undergo a series of chemical reactions to degrade them and ensure that all that's left is the DNA.'
Part of the data that first emerged was very raw, Aganovic said. 'It smelled like something went through a lawnmower, because you're getting everything — not just the fragrant petals, you're getting the plant's stem, the leaves, who knows what… You don't just get the genetics for the flower in the petal, right? It's all of the genetics.'
In other words, recreating an extinct bloom's scent is not, Aganovic points out, an exact science. Not least because scent is highly complex; for example, a jasmine flower or a rose is composed of hundreds — if not thousands — of different scent molecules and chemical compounds.
'We can draw an analogy to our own genetics,' explained Aganovic. 'We carry two copies of genes, one from our biological father, one from our biological mother, but even though our body carries those genes, it doesn't express both. What the body chooses to express is exactly the nuance here.' When the extinct plant DNA was sequenced, many different genes for the scent molecules were exposed — but not all 'turned on' when they were put into yeast, a living organism, she said. 'That narrowed down the olfactory profile and gave more confidence around the direction that the physical flower went in.'
This fragrance company is trying to recreate the scent of extinct blooms
The fragrances have evocative names such as Grassland Opera and Invisible Woods. (Erik Jacobs/Future Society via CNN Newsource)
Technology with a human touch
While Aganovic and her team were left with this genetic evidence, there was still work to do to interpret it. 'Having the DNA in yeast doesn't brew this beautiful, fine fragrance, it just gives us the scent profile. The actual blending and composition relies on perfumers' existing notes and compounds from their own libraries,' Aganovic explained.
Future Society does not use the DNA to regrow the extinct blooms. There are also scant — and subjective — records available. If no one living has experienced the flower first-hand, how does Future Society determine which flowers warrant a fragrance?
'This is what I really love about this work,' said Aganovic, who is a scientist by training but has been working in the beauty industry since 2014. 'It wasn't just down to the arrogance of science. While we had the data, we actually relied on different areas of expertise including perfumers and their knowledge of aroma chemicals and botany to look at the lineage of these plants, what living plants they were related to, where they were growing and what their environment was like… These elements all gave hints to how we might reconstruct the smell through a mixture of art and science.'
Indeed, Future Society worked with perfumers from famed scent houses Givaudan (which Arcaea also counts as an investor, alongside Chanel and Olaplex) and Robertet to source a mixture of fragrance notes — synthetic, natural, and bioengineered — inspired by the scent molecules of the extinct flowers to create the blends. The resulting scents are, according to the brand's website, 'tributes to' what the plants could have smelled like.
Storytelling through scent
Future Society worked with three different perfumers for their recreated scents, each of whom viewed the data through their own unique lens. Olivia Jan, who worked on the Grassland Opera fragrance imagined the scent of the herbaceous orbexilum stipulatum flower. 'The Orbexilum stipulatum flower grew near a waterfall, so I tried to make something wet, green, and lush,' Jan told Harper's Bazaar USA in 2023.
Perfumer Daniela Andrier, who formulated two fragrances for Future Society, wanted to tell the story of extinction from the perspective of the Earth. The Reclaimed Flame scent is a tribute to South Africa's extinct Leucadendron grandiflorum, which last bloomed in 1960, while Invisible Woods focuses on India's extinct Wendlandia angustifolia, which went extinct in 1917 due to drought. '(Andrier's) palette of ingredients relied on earthy, herbal ingredients because that was the feeling she wanted to evoke,' explained Aganovic.
Meanwhile, Jérôme Epinette formulated three fragrances, including the bestselling scent Solar Canopy, which is based on the hibiscadelphus wilderianus, a hibiscus flower from Hawaii which died out in 1912 due to deforestation. Epinette was fascinated by time travel, and wanted the wearer to feel like they were there with the flower in the forest or on the mountain. 'From the DNA data, we knew there were some earthy tones in there, hence the fragrance has vetiver (the scent of which some liken to dry grass or wet woods), but there were also some juicier, fruitier things — elements of lychee, some magnolia, some sour notes too,' added Aganovic.
While portions of the technology used in these projects are similar to the work being done by companies such as Colossal (who in April claimed to have brought the dire wolf back from extinction), Aganovic is keen to keep her distance. 'We are not fully resurrecting these flowers. We are a beauty company focused on self expression through personal scent, and I know that it's not sexy like, 'oh, we brought back the wolves,' but I think it's important to acknowledge,' she said.
'This de-extinction stuff (makes me) feel uneasy because… I definitely get whiffs of 'in the future, we will just de-extinct things,'' Aganovic continued. 'We can't be so arrogant to think we can just 'science' our way out of our problems, because sure, you know, technology means we can bring species back, but what we can't bring back is the relationship that certain populations had with that plant. Ultimately the human relationship with our environment is not just copy pasteable.'
By Nicole Mowbray, CNN
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
5 minutes ago
- Globe and Mail
Sprouts Farmers' E-Commerce Sales Jump 27%: Can It Keep Climbing?
Sprouts Farmers Market, Inc. SFM delivered a robust 27% year-over-year increase in e-commerce sales during the second quarter of 2025, with online transactions now accounting for about 15% of total revenues. The gain reflects balanced growth across all digital partners, including Instacart, Uber Eats, DoorDash and Sprouts' platform, While e-commerce continues to be the main pillar, the key question is: Can this level of performance be sustained? In the first quarter, e-commerce sales increased 28%, accounting for 15% of total revenues. The trend suggests that customers are drawn to Sprouts Farmers for its unique product offerings, with demand driven more by quality and value than by price. Instacart continues to deliver the largest online baskets, about double the size of typical in-store transactions. Uber Eats and DoorDash cater to more immediate needs, such as 'what's for dinner tonight' staples. Meanwhile, has emerged as the fastest-growing channel, benefiting from years of investment in customer engagement, site functionality and integration with Sprouts' brand identity. SFM is also betting on its new Sprouts Rewards loyalty program to accelerate this momentum. Initial pilot programs have shown that loyalty members are shopping more frequently and spending more. This initiative is a strategic step toward better understanding and serving its target customers. However, maintaining e-commerce growth at current levels will be somewhat challenging as penetration increases and comparisons become tougher. If Sprouts Farmers aims to replicate such a solid growth rate in future quarters, it will depend on innovation, effective digital marketing and a seamless customer experience. How SFM's E-Commerce Growth Compares to COST, WMT & TGT Costco Wholesale Corporation COST continues to show digital momentum, with e-commerce comparable sales rising 14.8% in the third quarter of fiscal 2025 and 15.1% in July. Costco is boosting its digital reach through efforts like Costco Logistics and a new Buy Now Pay Later option. Costco Logistics saw a 31% year-over-year increase in big and bulky e-commerce deliveries in the last reported quarter. Walmart Inc. WMT reported a 22% year-over-year increase in global e-commerce sales in the first quarter of fiscal 2026. Walmart continues to scale its digital business through faster delivery, improved fulfillment and marketplace expansion. With growing customer adoption, Walmart is firmly positioning itself as a strong digital retail competitor. Target Corporation TGT is making significant strides in digital sales and delivery speed, positioning itself as a strong competitor in the fast-delivery race. Target's digital sales rose 4.7% year over year in the first quarter of fiscal 2025, fueled by the rapid growth of Target Circle 360, which offers same-day delivery with no price markups. With more than 70% of digital orders fulfilled within a day, Target is enhancing convenience and customer loyalty through faster delivery. See our %%CTA_TEXT%% report – free today! 7 Best Stocks for the Next 30 Days Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Target Corporation (TGT): Free Stock Analysis Report Walmart Inc. (WMT): Free Stock Analysis Report Sprouts Farmers Market, Inc. (SFM): Free Stock Analysis Report


Globe and Mail
28 minutes ago
- Globe and Mail
Buy Big Tech Stock INTU On the Dip Now Before Earnings
TurboTax owner and financial technology titan Intuit Inc. INTU stock has dropped 12% after hitting fresh highs at the end of July. The downturn provides investors with a great opportunity to buy Intuit stock on the dip heading into its fourth-quarter fiscal 2025 earnings release on August 21. The tax software stock has more than tripled the Tech sector over the past 20 years. Intuit's expanding portfolio and AI enhancements will help it keep churning out double-digit sales and earnings growth. Plus, it looks like it's finding support at a critical technical range. Buy INTU Stock and Hold for AI Growth and Tax Stability Intuit averaged 16% revenue growth over the last decade, alongside roughly 15% average GAAP earnings expansion, driven by the consistent and evergreen nature of its TurboTax software. INTU's steady growth is impressive even among its mega-cap tech peers like Microsoft MSFT . INTU expanded its reach significantly over the last five years. It is now a one-stop shop for business and consumer finance, email marketing, and more via TurboTax, Credit Karma, QuickBooks, and Mailchimp, which boast roughly 100 million customers total. Intuit is crucially expanding its artificial intelligence efforts to make sure it doesn't lose ground to potential upstart AI rivals in tax prep software and more. The company's AI-powered TurboTax Live is an assisted tax preparation service that combines human experts with AI automation. Its sales surged 47% last quarter to $2 billion. AI-powered innovations and personalized offerings spurred growth across Intuit's entire portfolio. 'We're redefining what's possible with AI by becoming a one-stop shop of AI-agents and AI-enabled human experts to fuel the success of consumers and small and mid-market businesses,' CEO Sasan Goodarzi said in prepared remarks. INTU is projected to grow its sales by 15% in FY25 and 12% in fiscal 2026 to reach $20.94 billion vs. $16.29 billion last year, extending its streak of double-digit revenue growth. The technology powerhouse is projected to boost its adjusted earnings by 18% in its soon-to-be-reported fiscal 2025 and 14% next year. Plus, its upward earnings estimate revisions earn it a Zacks Rank #2 (Buy), and it has topped our bottom-line estimates in 19 out of the past 20 quarters. Buy the Financial Tech Stock On the Dip Now Intuit climbed roughly 3,000% in the past 20 years to more than triple Tech's 834% and crush Microsoft's 1,800%. Its outperformance remains significant over the past 10 years, up 700% vs. Tech's 410%. INTU was tracking Tech over the last few years until its recent tumble from its late July records. The stock fell not too long after INTU finally broke out meaningfully above its 2021 highs earlier this summer after meeting resistance there throughout 2024. INTU is finding support at its 21-week moving average and its previous peaks after falling from some of its most overbought RSI levels to its most oversold. One of the biggest things holding INTU stock back might be its valuation. Some could find it harder to justify paying up for Intuit given the uncertainty surrounding the long-term potential impact AI might have on its core tax segment and beyond. Still, Intuit trades at a small discount to its 10-year median and 50% below its highs at 41.7X forward earnings. Wall Street has been willing to pay a huge premium for Intuit's consistent growth. Now might be the time to consider buying Intuit stock on the dip heading into earnings, especially with the broader tech sector trading at all-time highs. Zacks Names #1 Semiconductor Stock This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Intuit Inc. (INTU): Free Stock Analysis Report


Globe and Mail
33 minutes ago
- Globe and Mail
2 Dividend Stocks to Buy and Hold
Key Points Apple is finding ways to overcome a significant challenge, and still has a strong long-term outlook. Novartis is posting strong financial results, and it has both a diversified lineup and a robust pipeline. Both companies have attractive dividend programs that should please income-focused investors. 10 stocks we like better than Apple › We've seen several investing trends sweep through Wall Street in recent years, from excitement about the cannabis market to the artificial intelligence (AI) industry that's now dominating headlines. Some of these opportunities turned out to be major disappointments, while others were major moneymakers. Although there's nothing wrong with looking to capitalize on new high-growth industries, it's also worth implementing time-tested strategies such as investing in dividend stocks -- that's one investment style that will never die. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » And if you're looking for top dividend-paying companies to put your money in right now, let's consider two excellent candidates: Apple (NASDAQ: AAPL) and Novartis (NYSE: NVS). 1. Apple Apple has been under pressure all year due to President Donald Trump's aggressive trade policies. The tech leader manufactures most of its iPhones abroad, especially in China. The administration has been imposing stiff tariffs on imports, which could erode Apple's profits. However, the company's CEO, Tim Cook, recently reached a deal with Trump that will exempt Apple from some potentially damaging tariffs in exchange for increasing its investment in U.S. manufacturing to $600 billion. These developments mitigate the threat from tariffs for Apple, making the stock even more attractive. Though the company no longer grows its revenue as fast as it once did, it still has a robust business and good long-term prospects. In its latest period (the third quarter of its fiscal year 2025, which ended June 28), sales increased by 10% year over year to $94 billion, while earnings per share jumped 12% year over year to $1.57. Apple has generated $96.2 billion in free cash flow (FCF) over the trailing-12-month period. Although FCF has declined by 11.6% compared to the same time last year, that's still a substantial amount of cash at its disposal, which it can reinvest in the business to improve its financial results. It could achieve this by finding more ways to monetize its vast ecosystem. The company has more than 2 billion active devices and over 1 billion paid subscriptions within its services segment, which boasts much juicier margins than the rest of the business. Moreover, Apple is still looking to make waves in the AI market. Although it trails some of its tech peers, the company has often been late to the party, only to launch a device that its loyal base of customers loves and that ends up becoming massively successful. Finally, Apple is a solid dividend stock. The company has doubled its payouts over the past decade and still has a modest cash payout ratio of 14%. Apple may have faced some headwinds recently, but it's proving its ability to navigate them. The stock looks highly attractive for long-term investors. 2. Novartis Novartis, a leading pharmaceutical company, has outperformed broader equities this year. Although the company faces some headwinds -- such as the threat of tariffs, and upcoming generic competition for Entresto, a medicine for heart failure and its top-selling drug -- its financial results remain strong. In the second quarter, net sales increased by 12% year over year to $14.1 billion, while net income rose 24% to $4 billion. True, Entresto's generic competitors hadn't entered the market yet in the second quarter, but Novartis continues to expect top-line growth in the high single digits for the year, and it recently increased its operating income guidance. For a company about to lose its best-selling medicine, that's impressive. It points to several key aspects of Novartis, including its diversified lineup featuring multiple blockbusters. Through the first six months of 2025, seven of the company's products had already exceeded $1 billion each in annual sales. Novartis is also excellent at developing new medicines. It will be able to offset Entresto-related losses thanks to some relatively newer products, including Kesimpta for multiple sclerosis, first approved in the U.S. in 2020, and Pluvicto, a cancer medicine that first earned the green light in 2022. Even newer medicines that will help drive top-line growth well into the next decade include Vanrafia, approved just this year to reduce high levels of protein in urine for certain patients, and Fabhalta, a medicine for some rare blood and kidney disorders, launched in 2023. These qualities are precisely what a drugmaker needs to perform well over the long run. As further evidence of its longevity, note that Novartis has increased its dividends for 28 consecutive years. The pharmaceutical giant looks like an outstanding stock to buy and hold through market downturns and volatility. Those looking for forever dividend stocks should strongly consider Novartis. Should you invest $1,000 in Apple right now? Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,544!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,113,059!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025